{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "83cf835a",
   "metadata": {},
   "source": [
    "# Loading Data Sets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "eab1492a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from pathlib import Path\n",
    "from sklearn.impute import SimpleImputer\n",
    "from sklearn.preprocessing import StandardScaler"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "34835a77",
   "metadata": {},
   "outputs": [],
   "source": [
    "def scan_directory(directory_path, file_extension=\".xlsx\"):\n",
    "    data_files = []\n",
    "    try:\n",
    "        directory = Path(directory_path)\n",
    "        for root, dirs, files in os.walk(directory):\n",
    "            for file in files:\n",
    "                if file.endswith(file_extension):\n",
    "                    file_path = Path(root) / file\n",
    "                    relative_path = str(file_path.relative_to(directory))\n",
    "                    data_files.append(relative_path)\n",
    "\n",
    "        return data_files\n",
    "    except Exception as e:\n",
    "        print(\"‚ùå Error scanning directory: {e}\")\n",
    "        return []\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "73c891c9",
   "metadata": {},
   "outputs": [],
   "source": [
    "def read_files(files_list):\n",
    "    dfs = []\n",
    "    for file in files_list:\n",
    "        df = pd.read_excel(file)\n",
    "        dfs.append(df)\n",
    "\n",
    "    return dfs"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b6c210d0",
   "metadata": {},
   "source": [
    "# Data Cleanup and Feature Engineering"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "1e1be815",
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_clean_df(list_of_dfs):\n",
    "    merged_df = list_of_dfs[0]\n",
    "    for i in range(1, len(list_of_dfs)):\n",
    "        merged_df = pd.merge(merged_df, list_of_dfs[i], on=\"Name\", how=\"inner\")\n",
    "\n",
    "    merged_df = merged_df.dropna(axis=1, how=\"all\")\n",
    "\n",
    "    return merged_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "d9480b25",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Kyte-Doolitle (GRAVY) table\n",
    "KD = {\n",
    "    \"A\": 1.8,\n",
    "    \"R\": -4.5,\n",
    "    \"N\": -3.5,\n",
    "    \"D\": -3.5,\n",
    "    \"C\": 2.5,\n",
    "    \"Q\": -3.5,\n",
    "    \"E\": -3.5,\n",
    "    \"G\": -0.4,\n",
    "    \"H\": -3.2,\n",
    "    \"I\": 4.5,\n",
    "    \"L\": 3.8,\n",
    "    \"K\": -3.9,\n",
    "    \"M\": 1.9,\n",
    "    \"F\": 2.8,\n",
    "    \"P\": -1.6,\n",
    "    \"S\": -0.8,\n",
    "    \"T\": -0.7,\n",
    "    \"W\": -0.9,\n",
    "    \"Y\": -1.3,\n",
    "    \"V\": 4.2,\n",
    "}\n",
    "\n",
    "HYDROPHOBIC = set(\"AILMVFWYV\")\n",
    "AROMATIC = set(\"FWY\")\n",
    "POSITIVE = set(\"KRH\")\n",
    "NEGATIVE = set(\"DE\")\n",
    "POLAR = set(\"STNQ\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "5bd58d7b",
   "metadata": {},
   "outputs": [],
   "source": [
    "def aa_counts(seq):\n",
    "    counts = {aa: 0 for aa in KD.keys()}\n",
    "    if isinstance(seq, str):\n",
    "        for ch in seq.upper():\n",
    "            if ch in counts:\n",
    "                counts[ch] += 1\n",
    "\n",
    "    return counts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "b68a22d3",
   "metadata": {},
   "outputs": [],
   "source": [
    "def seq_features(seq, prefix):\n",
    "    counts = aa_counts(seq)\n",
    "    L = sum(counts.values())\n",
    "    feats = {f\"{prefix}_len\": float(L)}\n",
    "\n",
    "    if L == 0:\n",
    "        for k in [\n",
    "            \"hydrophobic_frac\",\n",
    "            \"aromatic_frac\",\n",
    "            \"positive_frac\",\n",
    "            \"negative_frac\",\n",
    "            \"polar_frac\",\n",
    "            \"kd_gravy\",\n",
    "        ]:\n",
    "            feats[f\"{prefix}_{k}\"] = 0.0\n",
    "        for aa in KD.keys():\n",
    "            feats[f\"{prefix}_comp_{aa}\"] = 0.0\n",
    "\n",
    "        return feats\n",
    "\n",
    "    feats[f\"{prefix}_hydrophobic_frac\"] = (\n",
    "        sum(counts[a] for a in HYDROPHOBIC if a in counts) / L\n",
    "    )\n",
    "    feats[f\"{prefix}_aromatic_frac\"] = (\n",
    "        sum(counts[a] for a in AROMATIC if a in counts) / L\n",
    "    )\n",
    "    feats[f\"{prefix}_positive_frac\"] = (\n",
    "        sum(counts[a] for a in POSITIVE if a in counts) / L\n",
    "    )\n",
    "    feats[f\"{prefix}_negative_frac\"] = (\n",
    "        sum(counts[a] for a in NEGATIVE if a in counts) / L\n",
    "    )\n",
    "    feats[f\"{prefix}_polar_frac\"] = sum(counts[a] for a in POLAR if a in counts) / L\n",
    "    feats[f\"{prefix}_kd_gravy\"] = sum(KD[a] * counts[a] for a in KD.keys()) / L\n",
    "\n",
    "    for aa in KD.keys():\n",
    "        feats[f\"{prefix}_comp_{aa}\"] = counts[aa] / L\n",
    "\n",
    "    return feats\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "1a7a7633",
   "metadata": {},
   "outputs": [],
   "source": [
    "def engineer_sequence_features(df, seq_cols=(\"VH\", \"VL\")):\n",
    "    rows = []\n",
    "    for _, row in df.iterrows():\n",
    "        feats = {}\n",
    "        for col in seq_cols:\n",
    "            feats.update(seq_features(row.get(col, None), col))\n",
    "        rows.append(feats)\n",
    "    feat_df = pd.DataFrame(rows, index=df.index)\n",
    "    return feat_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9f6fd818",
   "metadata": {},
   "outputs": [],
   "source": [
    "def build_model_ready_from_merged(merged_df, target_col=\"Slope for Accelerated Stability\", seq_cols=(\"VH\", \"VL\"), include_assays=False, impute_strategy=\"median\"):\n",
    "    if target_col in merged_df.columns:\n",
    "        df = merged_df.dropna(subset=[target_col]).copy()\n",
    "    else:\n",
    "        df = merged_df.copy()\n",
    "\n",
    "    seq_feats = engineer_sequence_features(df, seq_cols=seq_cols)\n",
    "\n",
    "    if include_assays:\n",
    "        num_cols = df.select_dtypes(include=[np.number]).columns.tolist()\n",
    "        if target_col in num_cols:\n",
    "            num_cols.remove(target_col)\n",
    "        assay_feats = df[num_cols].copy()\n",
    "    else:\n",
    "        assay_feats = pd.DataFrame(index=df.index)\n",
    "\n",
    "    X_raw = pd.concat([seq_feats, assay_feats], axis=1)\n",
    "    feature_columns = X_raw.columns.tolist()\n",
    "    y = df[target_col].values if target_col in df.columns else None\n",
    "\n",
    "    imputer = SimpleImputer(strategy=impute_strategy)\n",
    "    scaler = StandardScaler()\n",
    "    X_imputed = imputer.fit_transform(X_raw)\n",
    "    X_scaled = scaler.fit_transform(X_imputed)\n",
    "    X = pd.DataFrame(X_scaled, index=df.index, columns=feature_columns)\n",
    "\n",
    "    return {\n",
    "        \"X\" : X,\n",
    "        \"X_pca_input\": X.copy(),\n",
    "        \"y\": y,\n",
    "        \"feature_columns\": feature_columns,\n",
    "        \"supervised_df\": df,\n",
    "        \"imputer\": imputer,\n",
    "        \"scaler\": scaler\n",
    "    }\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "fe9011ea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['data/pnas.1616408114.sd02.xlsx',\n",
       " 'data/pnas.1616408114.sd03.xlsx',\n",
       " 'data/pnas.1616408114.sd01.xlsx']"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "directory = os.getcwd()\n",
    "data_files = scan_directory(directory, file_extension=\".xlsx\")\n",
    "data_files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "491c872c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[            Name                                                 VH  \\\n",
       " 0     abituzumab  QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLE...   \n",
       " 1      abrilumab  QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLE...   \n",
       " 2     adalimumab  EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLE...   \n",
       " 3    alemtuzumab  QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLE...   \n",
       " 4     alirocumab  EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLD...   \n",
       " ..           ...                                                ...   \n",
       " 132  vedolizumab  QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLE...   \n",
       " 133   veltuzumab  QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLE...   \n",
       " 134  visilizumab  QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLE...   \n",
       " 135  zalutumumab  QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLE...   \n",
       " 136  zanolimumab  QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLE...   \n",
       " \n",
       "                                                     VL LC Class     Source  \\\n",
       " 0    DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKL...    kappa    WHO-INN   \n",
       " 1    DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKL...    kappa    WHO-INN   \n",
       " 2    DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKL...    kappa        PDB   \n",
       " 3    DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKL...    kappa        PDB   \n",
       " 4    DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKP...    kappa    WHO-INN   \n",
       " ..                                                 ...      ...        ...   \n",
       " 132  DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPG...    kappa    WHO-INN   \n",
       " 133  DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPW...    kappa    WHO-INN   \n",
       " 134  DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRL...    kappa  US Patent   \n",
       " 135  AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKL...    kappa  US Patent   \n",
       " 136  DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKL...    kappa  US Patent   \n",
       " \n",
       "     Source Detaileda Disclaimers and Known Issues  Unnamed: 7  \\\n",
       " 0              PL109                          NaN         NaN   \n",
       " 1              PL111                          NaN         NaN   \n",
       " 2               4NYL                          NaN         NaN   \n",
       " 3               1BEY                          NaN         NaN   \n",
       " 4              PL107                          NaN         NaN   \n",
       " ..               ...                          ...         ...   \n",
       " 132            PL100                          NaN         NaN   \n",
       " 133             PL98                          NaN         NaN   \n",
       " 134        US7381803                          NaN         NaN   \n",
       " 135        US8586041                          NaN         NaN   \n",
       " 136        US7722873                          NaN         NaN   \n",
       " \n",
       "                                                  Notes  \n",
       " 0    aPL and RL refer to WHO-INN publications for p...  \n",
       " 1                                                  NaN  \n",
       " 2                                                  NaN  \n",
       " 3                                                  NaN  \n",
       " 4                                                  NaN  \n",
       " ..                                                 ...  \n",
       " 132                                                NaN  \n",
       " 133                                                NaN  \n",
       " 134                                                NaN  \n",
       " 135                                                NaN  \n",
       " 136                                                NaN  \n",
       " \n",
       " [137 rows x 9 columns],\n",
       "                                                   Name  HEK Titer (mg/L)  \\\n",
       " 0                                           abituzumab         89.555458   \n",
       " 1                                            abrilumab        100.223196   \n",
       " 2                                           adalimumab        134.928638   \n",
       " 3                                          alemtuzumab        144.653543   \n",
       " 4                                           alirocumab         69.232345   \n",
       " ..                                                 ...               ...   \n",
       " 134                                        visilizumab        242.006377   \n",
       " 135                                        zalutumumab        200.506690   \n",
       " 136                                        zanolimumab        116.367688   \n",
       " 137                                                NaN               NaN   \n",
       " 138  aArbitrarily long RT of 25 min to indicate no ...               NaN   \n",
       " \n",
       "      Fab Tm by DSF (¬∞C)  SGAC-SINS AS100 ((NH4)2SO4 mM)  \\\n",
       " 0                  75.5                           900.0   \n",
       " 1                  71.0                           900.0   \n",
       " 2                  71.0                           900.0   \n",
       " 3                  74.5                          1000.0   \n",
       " 4                  71.5                           900.0   \n",
       " ..                  ...                             ...   \n",
       " 134                71.0                             0.0   \n",
       " 135                72.5                           900.0   \n",
       " 136                80.5                           700.0   \n",
       " 137                 NaN                             NaN   \n",
       " 138                 NaN                             NaN   \n",
       " \n",
       "      HIC Retention Time (Min)a  SMAC Retention Time (Min)a  \\\n",
       " 0                        9.227                       8.725   \n",
       " 1                        9.413                       8.699   \n",
       " 2                        8.816                       8.672   \n",
       " 3                        8.769                       8.672   \n",
       " 4                        9.036                       8.681   \n",
       " ..                         ...                         ...   \n",
       " 134                      9.007                       8.695   \n",
       " 135                      9.335                       8.738   \n",
       " 136                      9.586                       8.768   \n",
       " 137                        NaN                         NaN   \n",
       " 138                        NaN                         NaN   \n",
       " \n",
       "      Slope for Accelerated Stability  \\\n",
       " 0                            0.05563   \n",
       " 1                            0.02829   \n",
       " 2                            0.05069   \n",
       " 3                            0.06431   \n",
       " 4                            0.02920   \n",
       " ..                               ...   \n",
       " 134                          0.05760   \n",
       " 135                          0.04983   \n",
       " 136                          0.02569   \n",
       " 137                              NaN   \n",
       " 138                              NaN   \n",
       " \n",
       "      Poly-Specificity Reagent (PSR) SMP Score (0-1)  \\\n",
       " 0                                          0.166666   \n",
       " 1                                          0.000000   \n",
       " 2                                          0.000000   \n",
       " 3                                          0.000000   \n",
       " 4                                          0.000000   \n",
       " ..                                              ...   \n",
       " 134                                        0.418071   \n",
       " 135                                        0.000000   \n",
       " 136                                        0.127128   \n",
       " 137                                             NaN   \n",
       " 138                                             NaN   \n",
       " \n",
       "      Affinity-Capture Self-Interaction Nanoparticle Spectroscopy (AC-SINS) ‚àÜŒªmax (nm) Average  \\\n",
       " 0                                             1.458861                                          \n",
       " 1                                            -0.928526                                          \n",
       " 2                                             1.062328                                          \n",
       " 3                                            -0.789199                                          \n",
       " 4                                             1.230511                                          \n",
       " ..                                                 ...                                          \n",
       " 134                                          21.988193                                          \n",
       " 135                                          -0.796790                                          \n",
       " 136                                           1.457937                                          \n",
       " 137                                                NaN                                          \n",
       " 138                                                NaN                                          \n",
       " \n",
       "      CIC Retention Time (Min)  CSI-BLI Delta Response (nm)     ELISA  \\\n",
       " 0                       8.621                         0.00  1.137375   \n",
       " 1                       8.384                        -0.02  1.124624   \n",
       " 2                       8.865                        -0.01  1.075515   \n",
       " 3                       8.514                        -0.02  1.161491   \n",
       " 4                       8.757                        -0.01  1.196224   \n",
       " ..                        ...                          ...       ...   \n",
       " 134                     9.146                         0.01  1.880772   \n",
       " 135                     8.415                        -0.03  1.284363   \n",
       " 136                     8.610                        -0.01  1.102262   \n",
       " 137                       NaN                          NaN       NaN   \n",
       " 138                       NaN                          NaN       NaN   \n",
       " \n",
       "      BVP ELISA  \n",
       " 0     2.720799  \n",
       " 1     1.818303  \n",
       " 2     1.488186  \n",
       " 3     1.464226  \n",
       " 4     2.179700  \n",
       " ..         ...  \n",
       " 134   4.799334  \n",
       " 135   2.896506  \n",
       " 136   1.455574  \n",
       " 137        NaN  \n",
       " 138        NaN  \n",
       " \n",
       " [139 rows x 13 columns],\n",
       "             Name Light chain class Type Original mAb Isotype or Format  \\\n",
       " 0     abituzumab             kappa   ZU                           IgG2   \n",
       " 1      abrilumab             kappa   HU                           IgG2   \n",
       " 2     adalimumab             kappa   HU                           IgG1   \n",
       " 3    alemtuzumab             kappa   ZU                           IgG1   \n",
       " 4     alirocumab             kappa   HU                           IgG1   \n",
       " ..           ...               ...  ...                            ...   \n",
       " 132  vedolizumab             kappa   ZU                     IgG1AA-mut   \n",
       " 133   veltuzumab             kappa   ZU                           IgG1   \n",
       " 134  visilizumab             kappa   ZU                           IgG2   \n",
       " 135  zalutumumab             kappa   HU                           IgG1   \n",
       " 136  zanolimumab             kappa   HU                           IgG1   \n",
       " \n",
       "     Clinical Status Phagec  Year Name Proposed  Unnamed: 7  \\\n",
       " 0           Phase 2     No                2013         NaN   \n",
       " 1           Phase 2     No                2014         NaN   \n",
       " 2          Approved    Yes                1999         NaN   \n",
       " 3          Approved     No                2000         NaN   \n",
       " 4          Approved     No                2012         NaN   \n",
       " ..              ...    ...                 ...         ...   \n",
       " 132        Approved     No                2008         NaN   \n",
       " 133         Phase 2     No                2007         NaN   \n",
       " 134         Phase 3     No                2000         NaN   \n",
       " 135         Phase 3     No                2005         NaN   \n",
       " 136         Phase 3     No                2004         NaN   \n",
       " \n",
       "                                                  Notes  \n",
       " 0                            a Made with human isotype  \n",
       " 1                b Mixed chimeric, humanized LC and HC  \n",
       " 2    c Most as those molecules labeled Yes in the p...  \n",
       " 3                                                  NaN  \n",
       " 4                                                  NaN  \n",
       " ..                                                 ...  \n",
       " 132                                                NaN  \n",
       " 133                                                NaN  \n",
       " 134                                                NaN  \n",
       " 135                                                NaN  \n",
       " 136                                                NaN  \n",
       " \n",
       " [137 rows x 9 columns]]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfs = read_files(data_files)\n",
    "dfs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "c1519786",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>VH</th>\n",
       "      <th>VL</th>\n",
       "      <th>LC Class</th>\n",
       "      <th>Source</th>\n",
       "      <th>Source Detaileda</th>\n",
       "      <th>Disclaimers and Known Issues</th>\n",
       "      <th>Notes_x</th>\n",
       "      <th>HEK Titer (mg/L)</th>\n",
       "      <th>Fab Tm by DSF (¬∞C)</th>\n",
       "      <th>...</th>\n",
       "      <th>CSI-BLI Delta Response (nm)</th>\n",
       "      <th>ELISA</th>\n",
       "      <th>BVP ELISA</th>\n",
       "      <th>Light chain class</th>\n",
       "      <th>Type</th>\n",
       "      <th>Original mAb Isotype or Format</th>\n",
       "      <th>Clinical Status</th>\n",
       "      <th>Phagec</th>\n",
       "      <th>Year Name Proposed</th>\n",
       "      <th>Notes_y</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>abituzumab</td>\n",
       "      <td>QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLE...</td>\n",
       "      <td>DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKL...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>WHO-INN</td>\n",
       "      <td>PL109</td>\n",
       "      <td>NaN</td>\n",
       "      <td>aPL and RL refer to WHO-INN publications for p...</td>\n",
       "      <td>89.555458</td>\n",
       "      <td>75.5</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>1.137375</td>\n",
       "      <td>2.720799</td>\n",
       "      <td>kappa</td>\n",
       "      <td>ZU</td>\n",
       "      <td>IgG2</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>No</td>\n",
       "      <td>2013</td>\n",
       "      <td>a Made with human isotype</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>abrilumab</td>\n",
       "      <td>QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLE...</td>\n",
       "      <td>DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKL...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>WHO-INN</td>\n",
       "      <td>PL111</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100.223196</td>\n",
       "      <td>71.0</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.02</td>\n",
       "      <td>1.124624</td>\n",
       "      <td>1.818303</td>\n",
       "      <td>kappa</td>\n",
       "      <td>HU</td>\n",
       "      <td>IgG2</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>No</td>\n",
       "      <td>2014</td>\n",
       "      <td>b Mixed chimeric, humanized LC and HC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>adalimumab</td>\n",
       "      <td>EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLE...</td>\n",
       "      <td>DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKL...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>PDB</td>\n",
       "      <td>4NYL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>134.928638</td>\n",
       "      <td>71.0</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.01</td>\n",
       "      <td>1.075515</td>\n",
       "      <td>1.488186</td>\n",
       "      <td>kappa</td>\n",
       "      <td>HU</td>\n",
       "      <td>IgG1</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Yes</td>\n",
       "      <td>1999</td>\n",
       "      <td>c Most as those molecules labeled Yes in the p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>alemtuzumab</td>\n",
       "      <td>QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLE...</td>\n",
       "      <td>DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKL...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>PDB</td>\n",
       "      <td>1BEY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>144.653543</td>\n",
       "      <td>74.5</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.02</td>\n",
       "      <td>1.161491</td>\n",
       "      <td>1.464226</td>\n",
       "      <td>kappa</td>\n",
       "      <td>ZU</td>\n",
       "      <td>IgG1</td>\n",
       "      <td>Approved</td>\n",
       "      <td>No</td>\n",
       "      <td>2000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>alirocumab</td>\n",
       "      <td>EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLD...</td>\n",
       "      <td>DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKP...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>WHO-INN</td>\n",
       "      <td>PL107</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>69.232345</td>\n",
       "      <td>71.5</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.01</td>\n",
       "      <td>1.196224</td>\n",
       "      <td>2.179700</td>\n",
       "      <td>kappa</td>\n",
       "      <td>HU</td>\n",
       "      <td>IgG1</td>\n",
       "      <td>Approved</td>\n",
       "      <td>No</td>\n",
       "      <td>2012</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>vedolizumab</td>\n",
       "      <td>QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLE...</td>\n",
       "      <td>DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPG...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>WHO-INN</td>\n",
       "      <td>PL100</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>221.762037</td>\n",
       "      <td>80.5</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.02</td>\n",
       "      <td>1.152671</td>\n",
       "      <td>1.584027</td>\n",
       "      <td>kappa</td>\n",
       "      <td>ZU</td>\n",
       "      <td>IgG1AA-mut</td>\n",
       "      <td>Approved</td>\n",
       "      <td>No</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>veltuzumab</td>\n",
       "      <td>QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLE...</td>\n",
       "      <td>DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPW...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>WHO-INN</td>\n",
       "      <td>PL98</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>224.953517</td>\n",
       "      <td>70.0</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.02</td>\n",
       "      <td>0.888809</td>\n",
       "      <td>1.211236</td>\n",
       "      <td>kappa</td>\n",
       "      <td>ZU</td>\n",
       "      <td>IgG1</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>No</td>\n",
       "      <td>2007</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>visilizumab</td>\n",
       "      <td>QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLE...</td>\n",
       "      <td>DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRL...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>US Patent</td>\n",
       "      <td>US7381803</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>242.006377</td>\n",
       "      <td>71.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.01</td>\n",
       "      <td>1.880772</td>\n",
       "      <td>4.799334</td>\n",
       "      <td>kappa</td>\n",
       "      <td>ZU</td>\n",
       "      <td>IgG2</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>No</td>\n",
       "      <td>2000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>zalutumumab</td>\n",
       "      <td>QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLE...</td>\n",
       "      <td>AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKL...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>US Patent</td>\n",
       "      <td>US8586041</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200.506690</td>\n",
       "      <td>72.5</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.03</td>\n",
       "      <td>1.284363</td>\n",
       "      <td>2.896506</td>\n",
       "      <td>kappa</td>\n",
       "      <td>HU</td>\n",
       "      <td>IgG1</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>No</td>\n",
       "      <td>2005</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>zanolimumab</td>\n",
       "      <td>QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLE...</td>\n",
       "      <td>DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKL...</td>\n",
       "      <td>kappa</td>\n",
       "      <td>US Patent</td>\n",
       "      <td>US7722873</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>116.367688</td>\n",
       "      <td>80.5</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.01</td>\n",
       "      <td>1.102262</td>\n",
       "      <td>1.455574</td>\n",
       "      <td>kappa</td>\n",
       "      <td>HU</td>\n",
       "      <td>IgG1</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>No</td>\n",
       "      <td>2004</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>137 rows √ó 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            Name                                                 VH  \\\n",
       "0     abituzumab  QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLE...   \n",
       "1      abrilumab  QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLE...   \n",
       "2     adalimumab  EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLE...   \n",
       "3    alemtuzumab  QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLE...   \n",
       "4     alirocumab  EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLD...   \n",
       "..           ...                                                ...   \n",
       "132  vedolizumab  QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLE...   \n",
       "133   veltuzumab  QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLE...   \n",
       "134  visilizumab  QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLE...   \n",
       "135  zalutumumab  QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLE...   \n",
       "136  zanolimumab  QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLE...   \n",
       "\n",
       "                                                    VL LC Class     Source  \\\n",
       "0    DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKL...    kappa    WHO-INN   \n",
       "1    DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKL...    kappa    WHO-INN   \n",
       "2    DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKL...    kappa        PDB   \n",
       "3    DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKL...    kappa        PDB   \n",
       "4    DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKP...    kappa    WHO-INN   \n",
       "..                                                 ...      ...        ...   \n",
       "132  DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPG...    kappa    WHO-INN   \n",
       "133  DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPW...    kappa    WHO-INN   \n",
       "134  DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRL...    kappa  US Patent   \n",
       "135  AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKL...    kappa  US Patent   \n",
       "136  DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKL...    kappa  US Patent   \n",
       "\n",
       "    Source Detaileda Disclaimers and Known Issues  \\\n",
       "0              PL109                          NaN   \n",
       "1              PL111                          NaN   \n",
       "2               4NYL                          NaN   \n",
       "3               1BEY                          NaN   \n",
       "4              PL107                          NaN   \n",
       "..               ...                          ...   \n",
       "132            PL100                          NaN   \n",
       "133             PL98                          NaN   \n",
       "134        US7381803                          NaN   \n",
       "135        US8586041                          NaN   \n",
       "136        US7722873                          NaN   \n",
       "\n",
       "                                               Notes_x  HEK Titer (mg/L)  \\\n",
       "0    aPL and RL refer to WHO-INN publications for p...         89.555458   \n",
       "1                                                  NaN        100.223196   \n",
       "2                                                  NaN        134.928638   \n",
       "3                                                  NaN        144.653543   \n",
       "4                                                  NaN         69.232345   \n",
       "..                                                 ...               ...   \n",
       "132                                                NaN        221.762037   \n",
       "133                                                NaN        224.953517   \n",
       "134                                                NaN        242.006377   \n",
       "135                                                NaN        200.506690   \n",
       "136                                                NaN        116.367688   \n",
       "\n",
       "     Fab Tm by DSF (¬∞C)  ...  CSI-BLI Delta Response (nm)     ELISA  \\\n",
       "0                  75.5  ...                         0.00  1.137375   \n",
       "1                  71.0  ...                        -0.02  1.124624   \n",
       "2                  71.0  ...                        -0.01  1.075515   \n",
       "3                  74.5  ...                        -0.02  1.161491   \n",
       "4                  71.5  ...                        -0.01  1.196224   \n",
       "..                  ...  ...                          ...       ...   \n",
       "132                80.5  ...                        -0.02  1.152671   \n",
       "133                70.0  ...                        -0.02  0.888809   \n",
       "134                71.0  ...                         0.01  1.880772   \n",
       "135                72.5  ...                        -0.03  1.284363   \n",
       "136                80.5  ...                        -0.01  1.102262   \n",
       "\n",
       "     BVP ELISA  Light chain class  Type  Original mAb Isotype or Format  \\\n",
       "0     2.720799              kappa    ZU                            IgG2   \n",
       "1     1.818303              kappa    HU                            IgG2   \n",
       "2     1.488186              kappa    HU                            IgG1   \n",
       "3     1.464226              kappa    ZU                            IgG1   \n",
       "4     2.179700              kappa    HU                            IgG1   \n",
       "..         ...                ...   ...                             ...   \n",
       "132   1.584027              kappa    ZU                      IgG1AA-mut   \n",
       "133   1.211236              kappa    ZU                            IgG1   \n",
       "134   4.799334              kappa    ZU                            IgG2   \n",
       "135   2.896506              kappa    HU                            IgG1   \n",
       "136   1.455574              kappa    HU                            IgG1   \n",
       "\n",
       "     Clinical Status  Phagec  Year Name Proposed  \\\n",
       "0            Phase 2      No                2013   \n",
       "1            Phase 2      No                2014   \n",
       "2           Approved     Yes                1999   \n",
       "3           Approved      No                2000   \n",
       "4           Approved      No                2012   \n",
       "..               ...     ...                 ...   \n",
       "132         Approved      No                2008   \n",
       "133          Phase 2      No                2007   \n",
       "134          Phase 3      No                2000   \n",
       "135          Phase 3      No                2005   \n",
       "136          Phase 3      No                2004   \n",
       "\n",
       "                                               Notes_y  \n",
       "0                            a Made with human isotype  \n",
       "1                b Mixed chimeric, humanized LC and HC  \n",
       "2    c Most as those molecules labeled Yes in the p...  \n",
       "3                                                  NaN  \n",
       "4                                                  NaN  \n",
       "..                                                 ...  \n",
       "132                                                NaN  \n",
       "133                                                NaN  \n",
       "134                                                NaN  \n",
       "135                                                NaN  \n",
       "136                                                NaN  \n",
       "\n",
       "[137 rows x 27 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df = create_clean_df(dfs)\n",
    "merged_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "418043ef",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'X':        VH_len  VH_hydrophobic_frac  VH_aromatic_frac  VH_positive_frac  \\\n",
       " 0   -0.461214            -0.514420          0.244767         -0.662914   \n",
       " 1   -0.461214            -1.844884         -1.714445         -0.662914   \n",
       " 2    0.477196             1.585734         -0.904853         -0.245523   \n",
       " 3    0.477196            -0.576728         -0.427194          0.314161   \n",
       " 4   -0.461214            -0.514420         -1.224642         -0.089001   \n",
       " ..        ...                  ...               ...               ...   \n",
       " 132  0.477196            -0.144236          0.050465          0.314161   \n",
       " 133  0.477196            -1.009221          1.005783         -0.245523   \n",
       " 134  0.164393             1.333446          0.595792          1.498826   \n",
       " 135  1.728410             1.298559          0.268277          1.182791   \n",
       " 136 -1.399624             0.006196         -0.053374         -1.102083   \n",
       " \n",
       "      VH_negative_frac  VH_polar_frac  VH_kd_gravy  VH_comp_A  VH_comp_R  \\\n",
       " 0            0.353617       0.786559    -0.548799   0.789698  -0.184239   \n",
       " 1            2.027756       0.481022    -0.238080  -0.344337  -1.854647   \n",
       " 2            1.303680      -0.677997     1.027638   1.769091   0.289734   \n",
       " 3           -0.328952       0.215887     0.390044  -0.442745   0.832731   \n",
       " 4           -0.204429       0.175486     0.558136   0.222681   0.372564   \n",
       " ..                ...            ...          ...        ...        ...   \n",
       " 132          1.303680      -0.380036    -0.948272   0.110214  -0.253264   \n",
       " 133          0.215259       0.811810    -1.566927   0.663173  -1.882257   \n",
       " 134         -0.288136      -0.598541    -0.868257   2.377346  -0.778162   \n",
       " 135          0.567907      -1.848389     0.388277  -0.566607   1.236722   \n",
       " 136         -1.791222       1.387005     1.013970  -0.822603  -1.254268   \n",
       " \n",
       "      VH_comp_N  ...  VL_comp_L  VL_comp_K  VL_comp_M  VL_comp_F  VL_comp_P  \\\n",
       " 0    -1.089878  ...  -1.518638   1.154409   0.048201  -0.129715  -0.313858   \n",
       " 1    -2.411604  ...  -0.978244   0.365806   0.048201   0.794233  -0.313858   \n",
       " 2     0.166308  ...  -0.437851   0.365806   0.048201  -1.053663  -0.313858   \n",
       " 3    -0.478170  ...  -0.437851   1.943012   0.048201  -0.129715  -0.313858   \n",
       " 4     2.214437  ...   0.384695  -0.590287  -0.014749  -0.325951  -0.620949   \n",
       " ..         ...  ...        ...        ...        ...        ...        ...   \n",
       " 132  -0.478170  ...   0.425814   0.189779  -0.004725  -0.294705   1.269732   \n",
       " 133  -0.478170  ...  -1.493147   0.403005   0.059385  -0.094849   1.686740   \n",
       " 134  -1.111907  ...  -1.493147   1.199047   1.256110  -0.094849   0.713722   \n",
       " 135  -0.540040  ...   0.642937   0.365806  -1.137340   0.794233  -0.313858   \n",
       " 136   0.978910  ...  -0.437851   0.365806   0.048201   0.794233  -0.313858   \n",
       " \n",
       "      VL_comp_S  VL_comp_T  VL_comp_W  VL_comp_Y  VL_comp_V  \n",
       " 0    -0.370240   1.127227  -0.781537   1.782788  -0.763936  \n",
       " 1     0.554407  -0.957114   2.306971  -1.421013  -0.192497  \n",
       " 2    -0.832563   0.432447  -0.781537   0.981838  -0.192497  \n",
       " 3    -1.294887   1.127227  -0.781537  -0.620062  -0.763936  \n",
       " 4    -1.176237   0.063537   0.598726   1.442562   0.196890  \n",
       " ..         ...        ...        ...        ...        ...  \n",
       " 132  -0.238147  -1.205249  -0.850477   0.731541   1.317733  \n",
       " 133   0.628553   1.199327   2.350676  -0.582282  -0.165542  \n",
       " 134   2.028608   0.497992   0.791854  -0.582282  -0.165542  \n",
       " 135   1.016730  -0.262333  -0.781537  -0.620062  -0.192497  \n",
       " 136   1.016730  -0.262333   0.762717  -0.620062  -0.763936  \n",
       " \n",
       " [137 rows x 54 columns],\n",
       " 'X_pca_input':        VH_len  VH_hydrophobic_frac  VH_aromatic_frac  VH_positive_frac  \\\n",
       " 0   -0.461214            -0.514420          0.244767         -0.662914   \n",
       " 1   -0.461214            -1.844884         -1.714445         -0.662914   \n",
       " 2    0.477196             1.585734         -0.904853         -0.245523   \n",
       " 3    0.477196            -0.576728         -0.427194          0.314161   \n",
       " 4   -0.461214            -0.514420         -1.224642         -0.089001   \n",
       " ..        ...                  ...               ...               ...   \n",
       " 132  0.477196            -0.144236          0.050465          0.314161   \n",
       " 133  0.477196            -1.009221          1.005783         -0.245523   \n",
       " 134  0.164393             1.333446          0.595792          1.498826   \n",
       " 135  1.728410             1.298559          0.268277          1.182791   \n",
       " 136 -1.399624             0.006196         -0.053374         -1.102083   \n",
       " \n",
       "      VH_negative_frac  VH_polar_frac  VH_kd_gravy  VH_comp_A  VH_comp_R  \\\n",
       " 0            0.353617       0.786559    -0.548799   0.789698  -0.184239   \n",
       " 1            2.027756       0.481022    -0.238080  -0.344337  -1.854647   \n",
       " 2            1.303680      -0.677997     1.027638   1.769091   0.289734   \n",
       " 3           -0.328952       0.215887     0.390044  -0.442745   0.832731   \n",
       " 4           -0.204429       0.175486     0.558136   0.222681   0.372564   \n",
       " ..                ...            ...          ...        ...        ...   \n",
       " 132          1.303680      -0.380036    -0.948272   0.110214  -0.253264   \n",
       " 133          0.215259       0.811810    -1.566927   0.663173  -1.882257   \n",
       " 134         -0.288136      -0.598541    -0.868257   2.377346  -0.778162   \n",
       " 135          0.567907      -1.848389     0.388277  -0.566607   1.236722   \n",
       " 136         -1.791222       1.387005     1.013970  -0.822603  -1.254268   \n",
       " \n",
       "      VH_comp_N  ...  VL_comp_L  VL_comp_K  VL_comp_M  VL_comp_F  VL_comp_P  \\\n",
       " 0    -1.089878  ...  -1.518638   1.154409   0.048201  -0.129715  -0.313858   \n",
       " 1    -2.411604  ...  -0.978244   0.365806   0.048201   0.794233  -0.313858   \n",
       " 2     0.166308  ...  -0.437851   0.365806   0.048201  -1.053663  -0.313858   \n",
       " 3    -0.478170  ...  -0.437851   1.943012   0.048201  -0.129715  -0.313858   \n",
       " 4     2.214437  ...   0.384695  -0.590287  -0.014749  -0.325951  -0.620949   \n",
       " ..         ...  ...        ...        ...        ...        ...        ...   \n",
       " 132  -0.478170  ...   0.425814   0.189779  -0.004725  -0.294705   1.269732   \n",
       " 133  -0.478170  ...  -1.493147   0.403005   0.059385  -0.094849   1.686740   \n",
       " 134  -1.111907  ...  -1.493147   1.199047   1.256110  -0.094849   0.713722   \n",
       " 135  -0.540040  ...   0.642937   0.365806  -1.137340   0.794233  -0.313858   \n",
       " 136   0.978910  ...  -0.437851   0.365806   0.048201   0.794233  -0.313858   \n",
       " \n",
       "      VL_comp_S  VL_comp_T  VL_comp_W  VL_comp_Y  VL_comp_V  \n",
       " 0    -0.370240   1.127227  -0.781537   1.782788  -0.763936  \n",
       " 1     0.554407  -0.957114   2.306971  -1.421013  -0.192497  \n",
       " 2    -0.832563   0.432447  -0.781537   0.981838  -0.192497  \n",
       " 3    -1.294887   1.127227  -0.781537  -0.620062  -0.763936  \n",
       " 4    -1.176237   0.063537   0.598726   1.442562   0.196890  \n",
       " ..         ...        ...        ...        ...        ...  \n",
       " 132  -0.238147  -1.205249  -0.850477   0.731541   1.317733  \n",
       " 133   0.628553   1.199327   2.350676  -0.582282  -0.165542  \n",
       " 134   2.028608   0.497992   0.791854  -0.582282  -0.165542  \n",
       " 135   1.016730  -0.262333  -0.781537  -0.620062  -0.192497  \n",
       " 136   1.016730  -0.262333   0.762717  -0.620062  -0.763936  \n",
       " \n",
       " [137 rows x 54 columns],\n",
       " 'y': array([ 0.05563 ,  0.02829 ,  0.05069 ,  0.06431 ,  0.0292  ,  0.0708  ,\n",
       "         0.0556  ,  0.07017 ,  0.0476  ,  0.0404  ,  0.1304  ,  0.0243  ,\n",
       "         0.2198  ,  0.09126 ,  0.1252  ,  0.067   , -0.003086,  0.1054  ,\n",
       "         0.01717 ,  0.03791 ,  0.07491 ,  0.04289 ,  0.05474 ,  0.1617  ,\n",
       "         0.05306 ,  0.255   ,  0.04786 ,  0.0033  ,  0.02794 ,  0.1466  ,\n",
       "         0.06363 ,  0.01043 ,  0.0098  ,  0.02829 ,  0.05514 ,  0.02874 ,\n",
       "         0.008   ,  0.      ,  0.0998  ,  0.      ,  0.04114 ,  0.08966 ,\n",
       "         0.02629 ,  0.2009  ,  0.0298  ,  0.006029,  0.06657 ,  0.06932 ,\n",
       "         0.04614 ,  0.06446 ,  0.01897 ,  0.03766 ,  0.05526 ,  0.07229 ,\n",
       "         0.03135 ,  0.01174 ,  0.06671 ,  0.04534 ,  0.07129 ,  0.03154 ,\n",
       "         0.303   ,  0.06274 ,  0.1931  ,  0.0393  ,  0.06543 ,  0.1812  ,\n",
       "         0.02517 ,  0.03963 ,  0.1614  ,  0.08749 ,  0.0047  ,  0.03277 ,\n",
       "         0.048   ,  0.00174 ,  0.06686 ,  0.0164  ,  0.04903 ,  0.04451 ,\n",
       "         0.03631 ,  0.04454 ,  0.03829 ,  0.01877 ,  0.0204  ,  0.04357 ,\n",
       "         0.02743 ,  0.0128  ,  0.0237  ,  0.02874 ,  0.2885  ,  0.04469 ,\n",
       "         0.04511 ,  0.04311 ,  0.08814 ,  0.07229 ,  0.05569 ,  0.03666 ,\n",
       "         0.03631 ,  0.02071 ,  0.08654 ,  0.05371 ,  0.0334  ,  0.03917 ,\n",
       "         0.06846 ,  0.05931 ,  0.1568  ,  0.001743,  0.02434 ,  0.0942  ,\n",
       "         0.06217 ,  1.2728  ,  0.025   ,  0.04534 ,  0.02831 ,  0.04986 ,\n",
       "         0.0492  ,  0.1544  ,  0.01314 ,  0.0133  ,  0.1421  ,  0.03969 ,\n",
       "         0.0618  ,  0.0166  ,  0.06126 ,  0.0029  , -0.005   ,  0.04516 ,\n",
       "         0.0131  ,  0.007743,  0.04383 ,  0.01757 ,  0.01389 ,  0.02254 ,\n",
       "         0.06906 ,  0.0399  ,  0.0576  ,  0.04983 ,  0.02569 ]),\n",
       " 'feautre_columns': ['VH_len',\n",
       "  'VH_hydrophobic_frac',\n",
       "  'VH_aromatic_frac',\n",
       "  'VH_positive_frac',\n",
       "  'VH_negative_frac',\n",
       "  'VH_polar_frac',\n",
       "  'VH_kd_gravy',\n",
       "  'VH_comp_A',\n",
       "  'VH_comp_R',\n",
       "  'VH_comp_N',\n",
       "  'VH_comp_D',\n",
       "  'VH_comp_C',\n",
       "  'VH_comp_Q',\n",
       "  'VH_comp_E',\n",
       "  'VH_comp_G',\n",
       "  'VH_comp_H',\n",
       "  'VH_comp_I',\n",
       "  'VH_comp_L',\n",
       "  'VH_comp_K',\n",
       "  'VH_comp_M',\n",
       "  'VH_comp_F',\n",
       "  'VH_comp_P',\n",
       "  'VH_comp_S',\n",
       "  'VH_comp_T',\n",
       "  'VH_comp_W',\n",
       "  'VH_comp_Y',\n",
       "  'VH_comp_V',\n",
       "  'VL_len',\n",
       "  'VL_hydrophobic_frac',\n",
       "  'VL_aromatic_frac',\n",
       "  'VL_positive_frac',\n",
       "  'VL_negative_frac',\n",
       "  'VL_polar_frac',\n",
       "  'VL_kd_gravy',\n",
       "  'VL_comp_A',\n",
       "  'VL_comp_R',\n",
       "  'VL_comp_N',\n",
       "  'VL_comp_D',\n",
       "  'VL_comp_C',\n",
       "  'VL_comp_Q',\n",
       "  'VL_comp_E',\n",
       "  'VL_comp_G',\n",
       "  'VL_comp_H',\n",
       "  'VL_comp_I',\n",
       "  'VL_comp_L',\n",
       "  'VL_comp_K',\n",
       "  'VL_comp_M',\n",
       "  'VL_comp_F',\n",
       "  'VL_comp_P',\n",
       "  'VL_comp_S',\n",
       "  'VL_comp_T',\n",
       "  'VL_comp_W',\n",
       "  'VL_comp_Y',\n",
       "  'VL_comp_V'],\n",
       " 'supervised_df':             Name                                                 VH  \\\n",
       " 0     abituzumab  QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLE...   \n",
       " 1      abrilumab  QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLE...   \n",
       " 2     adalimumab  EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLE...   \n",
       " 3    alemtuzumab  QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLE...   \n",
       " 4     alirocumab  EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLD...   \n",
       " ..           ...                                                ...   \n",
       " 132  vedolizumab  QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLE...   \n",
       " 133   veltuzumab  QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLE...   \n",
       " 134  visilizumab  QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLE...   \n",
       " 135  zalutumumab  QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLE...   \n",
       " 136  zanolimumab  QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLE...   \n",
       " \n",
       "                                                     VL LC Class     Source  \\\n",
       " 0    DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKL...    kappa    WHO-INN   \n",
       " 1    DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKL...    kappa    WHO-INN   \n",
       " 2    DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKL...    kappa        PDB   \n",
       " 3    DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKL...    kappa        PDB   \n",
       " 4    DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKP...    kappa    WHO-INN   \n",
       " ..                                                 ...      ...        ...   \n",
       " 132  DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPG...    kappa    WHO-INN   \n",
       " 133  DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPW...    kappa    WHO-INN   \n",
       " 134  DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRL...    kappa  US Patent   \n",
       " 135  AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKL...    kappa  US Patent   \n",
       " 136  DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKL...    kappa  US Patent   \n",
       " \n",
       "     Source Detaileda Disclaimers and Known Issues  \\\n",
       " 0              PL109                          NaN   \n",
       " 1              PL111                          NaN   \n",
       " 2               4NYL                          NaN   \n",
       " 3               1BEY                          NaN   \n",
       " 4              PL107                          NaN   \n",
       " ..               ...                          ...   \n",
       " 132            PL100                          NaN   \n",
       " 133             PL98                          NaN   \n",
       " 134        US7381803                          NaN   \n",
       " 135        US8586041                          NaN   \n",
       " 136        US7722873                          NaN   \n",
       " \n",
       "                                                Notes_x  HEK Titer (mg/L)  \\\n",
       " 0    aPL and RL refer to WHO-INN publications for p...         89.555458   \n",
       " 1                                                  NaN        100.223196   \n",
       " 2                                                  NaN        134.928638   \n",
       " 3                                                  NaN        144.653543   \n",
       " 4                                                  NaN         69.232345   \n",
       " ..                                                 ...               ...   \n",
       " 132                                                NaN        221.762037   \n",
       " 133                                                NaN        224.953517   \n",
       " 134                                                NaN        242.006377   \n",
       " 135                                                NaN        200.506690   \n",
       " 136                                                NaN        116.367688   \n",
       " \n",
       "      Fab Tm by DSF (¬∞C)  ...  CSI-BLI Delta Response (nm)     ELISA  \\\n",
       " 0                  75.5  ...                         0.00  1.137375   \n",
       " 1                  71.0  ...                        -0.02  1.124624   \n",
       " 2                  71.0  ...                        -0.01  1.075515   \n",
       " 3                  74.5  ...                        -0.02  1.161491   \n",
       " 4                  71.5  ...                        -0.01  1.196224   \n",
       " ..                  ...  ...                          ...       ...   \n",
       " 132                80.5  ...                        -0.02  1.152671   \n",
       " 133                70.0  ...                        -0.02  0.888809   \n",
       " 134                71.0  ...                         0.01  1.880772   \n",
       " 135                72.5  ...                        -0.03  1.284363   \n",
       " 136                80.5  ...                        -0.01  1.102262   \n",
       " \n",
       "      BVP ELISA  Light chain class  Type  Original mAb Isotype or Format  \\\n",
       " 0     2.720799              kappa    ZU                            IgG2   \n",
       " 1     1.818303              kappa    HU                            IgG2   \n",
       " 2     1.488186              kappa    HU                            IgG1   \n",
       " 3     1.464226              kappa    ZU                            IgG1   \n",
       " 4     2.179700              kappa    HU                            IgG1   \n",
       " ..         ...                ...   ...                             ...   \n",
       " 132   1.584027              kappa    ZU                      IgG1AA-mut   \n",
       " 133   1.211236              kappa    ZU                            IgG1   \n",
       " 134   4.799334              kappa    ZU                            IgG2   \n",
       " 135   2.896506              kappa    HU                            IgG1   \n",
       " 136   1.455574              kappa    HU                            IgG1   \n",
       " \n",
       "      Clinical Status  Phagec  Year Name Proposed  \\\n",
       " 0            Phase 2      No                2013   \n",
       " 1            Phase 2      No                2014   \n",
       " 2           Approved     Yes                1999   \n",
       " 3           Approved      No                2000   \n",
       " 4           Approved      No                2012   \n",
       " ..               ...     ...                 ...   \n",
       " 132         Approved      No                2008   \n",
       " 133          Phase 2      No                2007   \n",
       " 134          Phase 3      No                2000   \n",
       " 135          Phase 3      No                2005   \n",
       " 136          Phase 3      No                2004   \n",
       " \n",
       "                                                Notes_y  \n",
       " 0                            a Made with human isotype  \n",
       " 1                b Mixed chimeric, humanized LC and HC  \n",
       " 2    c Most as those molecules labeled Yes in the p...  \n",
       " 3                                                  NaN  \n",
       " 4                                                  NaN  \n",
       " ..                                                 ...  \n",
       " 132                                                NaN  \n",
       " 133                                                NaN  \n",
       " 134                                                NaN  \n",
       " 135                                                NaN  \n",
       " 136                                                NaN  \n",
       " \n",
       " [137 rows x 27 columns],\n",
       " 'imputer': SimpleImputer(strategy='median'),\n",
       " 'scaler': StandardScaler()}"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "model_ready_df = build_model_ready_from_merged(merged_df, target_col=\"Slope for Accelerated Stability\", seq_cols=(\"VH\", \"VL\"), include_assays=False, impute_strategy=\"median\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "siads696_milestoneII",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
